Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Transparency and public accessibility of clinical trial information in Croatia: how it affects patient participation in clinical trials (CROSBI ID 240394)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Šolić, Ivana ; Stipčić, Ana ; Pavličević, Ivančica ; Marušić, Ana Transparency and public accessibility of clinical trial information in Croatia: how it affects patient participation in clinical trials // Biochemia medica, 27 (2017), 2; 259-269. doi: 10.11613/BM.2017.027

Podaci o odgovornosti

Šolić, Ivana ; Stipčić, Ana ; Pavličević, Ivančica ; Marušić, Ana

engleski

Transparency and public accessibility of clinical trial information in Croatia: how it affects patient participation in clinical trials

Introduction: Despite increased visibility of clinical trials through international trial registries, patients often remain uninformed of their existence, especially if they do not have access to adequate information about clinical research, including the language of the information. The aim of this study was to describe the context for transparency of clinical trials in Croatia in relation to countries in Central and Eastern Europe, and to assess how informed Croatian patients are about clinical trials and their accessibility. Materials and methods: We assessed the transparency of clinical trials from the data available in the public domain. We also conducted an anonymous survey on a convenience sample of 257 patients visiting two family medicine offices or an oncology department in south Croatia, and members of national patients’ associations. Results: Despite legal provisions for transparency of clinical trials in Croatia, they are still not sufficiently visible in the public domain. Among countries from Central and Eastern Europe, Croatia has the fewest number of registered trials in the EU Clinical Trials Registry. 66% of the patients in the survey were aware of the existence of clinical trials but only 15% were informed about possibilities of participating in a trial. Although 58% of the respondents were willing to try new treatments, only 6% actually participated in a clinical trial. Only 2% of the respondents were aware of publicly available trial registries. Conclusions: Our study demonstrates that there is low transparency of clinical trials in Croatia, and that Croatian patients are not fully aware of clinical trials and the possibilities of participating in them, despite reported availability of Internet resources and good communication with their physicians. There is a need for active policy measures to increase the awareness of and access to clinical trials to patients in Croatia, particularly in their own language.

access to information ; awareness ; patient participation ; clinical trials ; registries

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

27 (2)

2017.

259-269

objavljeno

1330-0962

1846-7482

10.11613/BM.2017.027

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost